Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 2/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | MAPT | P10636 | 4/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | XBP1 | P17861 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | CA12 | O43570 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA7 | P43166 | 3/20 | 0.50 |
| ▸ | CA9 | Q16790 | 3/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | XDH | P47989 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30570165 | 1.00 | CNR2 (0.56) | CNR2ATMALDH1A1MAPTMEN1 | |
| SCHEMBL67540 | 0.87 | ALDH1A1 (0.62) | CNR2ALDH1A1MAPTMEN1HPGD | |
| SCHEMBL588343 | 0.87 | ALDH1A1 (0.62) | CNR2ALDH1A1MAPTMEN1HPGD | |
| SCHEMBL70232 | 0.85 | ATM (0.61) | CNR2ATMALDH1A1MAPTCA12 | |
| Methyl 3,5-Dimethylbenzoate SCHEMBL334346 | 0.85 | CNR2 (0.66) | CNR2ATMALDH1A1MAPTMEN1 | |
| SCHEMBL27866773 | 0.82 | HTR3E (0.40) | CNR2ALDH1A1MAPTMEN1HPGD | |
| SCHEMBL15615318 | 0.81 | CA12 (0.56) | CNR2MEN1KMT2ACA12CA1 | |
| SCHEMBL4734613 | 0.80 | ALDH1A1 (0.56) | CNR2ALDH1A1MAPTMEN1HPGD | |
| SCHEMBL5185978 | 0.80 | CA12 (0.73) | CNR2ALDH1A1MAPTMEN1HPGD | |
| SCHEMBL16961231 | 0.80 | ALDH1A1 (0.56) | CNR2ALDH1A1MAPTMEN1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025131957-A1 | DIAZINONE COMPOUNDS FOR THE CONTROL OF INVERTEBRATE PESTS | BASF SE (DE) | 2025-06-26 | — | — | WO | disclosed |
| US-12030866-B2 | 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD | SPRINGWORKS THERAPEUTICS, INC. (US) | 2024-07-09 | — | — | US | disclosed |
| CN-115551839-B | Heteroaryl-triazole compounds as pesticides | 拜耳公司 | 2024-06-04 | — | — | CN | disclosed |
| US-20230346764-A1 | Methods and Compositions for Treating Pruritus, Xerosis, and Associated Disease Using CCR3-Inhibitors | ALKAHEST, INC. | 2023-11-02 | — | — | US | disclosed |
| EP-3875151-B1 | ALPHA-METHYL-SUBSTITUTED DIAZABICYCLO [4.3.1] DECANE DERIVATES FOR TREATMENT OF PSYCHIATRIC DISORDERS | UNIV DARMSTADT TECH (DE) | 2023-09-20 | — | — | EP | disclosed |
| CN-116730977-A | Novel aryl heterocyclic compound, and preparation method and application thereof | 华东理工大学 | 2023-09-12 | — | — | CN | disclosed |
| CN-116724015-A | Process for preparing insecticidal anthranilamides | UPL有限公司 | 2023-09-08 | — | — | CN | disclosed |
| US-20230278982-A1 | 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD | KU LEUVEN R&D (BE) | 2023-09-07 | — | — | US | disclosed |
| US-20230148601-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2023-05-18 | — | — | US | disclosed |
| US-20230148601-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2023-05-18 | — | — | US | disclosed |
| US-20120149661-A1 | TETRA-SUBSTITUTED HETEROARYL COMPOUNDS AND THEIR USE AS MDM2 AND/OR MDM4 MODULATORS | NOVARTIS AG (CH) | 2012-06-14 | — | — | US | disclosed |
| US-20110190301-A1 | SUBSTITUTED CYCLOPENTANES OR CYCLOPENTANONES AS THERAPEUTIC AGENTS | ALLERGAN, INC. (US) | 2011-08-04 | — | — | US | disclosed |
| US-7763597-B2 | Salts | ASTRAZENECA AB (SE) | 2010-07-27 | — | — | US | disclosed |
| WO-2009034029-A2 | 1-SUBSTITUTED 4-HETEROCYCLYLPIPERIDINES FOR USE AS CGRP ANTAGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-03-19 | — | — | WO | disclosed |
| US-20080269176-A1 | New Salts | ASTRAZENECA AB (SE) | 2008-10-30 | — | — | US | disclosed |
| US-7329769-B2 | Catalytic boronate ester synthesis from boron reagents and hydrocarbons | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2008-02-12 | — | — | US | disclosed |
| US-7273858-B2 | Sulfonic acid salts of 2-(p-(alkoxyamidino)benzylaminocarbonyl)azetidin-1-yl 3-chloro-5-(fluorinated alkoxy)-alpha-hydroxybenzyl ketone; competitive inhibitors of trypsin-like proteases, such as thrombin; anticoagulants | ASTRAZENECA AB (SE) | 2007-09-25 | — | — | US | disclosed |
| EP-0604019-B1 | N-Acetonylbenzamides and their use as fungicides | ROHM & HAAS (US) | 1996-05-08 | — | — | EP | disclosed |
| EP-0604019-A1 | N-Acetonylbenzamides and their use as fungicides | ROHM AND HAAS COMPANY (US) | 1994-06-29 | — | — | EP | disclosed |
| US-5254584-A | Controlling phytopathogens | ROHM AND HAAS COMPANY (US) | 1993-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080269176-A1 | New Salts | PRSS1, PRSS2, CTRL | CNR2 3541/4885ATM 3177/4885ALDH1A1 898/4885 |
| US-20230148601-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | PRXL2A, GLRX3, CYP4F3 | CNR2 1146/4885ATM 3528/4885ALDH1A1 4213/4885 |
| US-20120149661-A1 | TETRA-SUBSTITUTED HETEROARYL COMPOUNDS AND THEIR USE AS MDM2 AND/OR MDM4 MODULATORS | MDM4, MDM2, TP53 | CNR2 3405/4885ATM 660/4885ALDH1A1 4361/4885 |
| US-20230278982-A1 | 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD | YAP1, TEAD3, TEAD2 | CNR2 4202/4885ATM 400/4885ALDH1A1 2212/4885 |
| US-20230346764-A1 | Methods and Compositions for Treating Pruritus, Xerosis, and Associated Disease Using CCR3-Inhibitors | CCR3, CCR1, CCR4 | CNR2 553/4885ATM 3275/4885ALDH1A1 4741/4885 |
| US-20110190301-A1 | SUBSTITUTED CYCLOPENTANES OR CYCLOPENTANONES AS THERAPEUTIC AGENTS | PTGIS, PTGIR, PDE3A | CNR2 329/4885ATM 3586/4885ALDH1A1 775/4885 |
| US-12030866-B2 | 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD | YAP1, TEAD3, TEAD2 | CNR2 4202/4885ATM 400/4885ALDH1A1 2212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.